Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 3Breast Neoplasms 3Polycythemia Vera 2Myeloproliferative Disorders 2Lymphoma 2Lung Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Thymic aplasia 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Severe Combined Immunodeficiency 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Primary Dysautonomias 1Polycystic Ovary Syndrome 1Neuroblastoma 1Neoplasms 1Mucopolysaccharidosis I 1Metabolic Syndrome 1Melanoma 1Liver Neoplasms 1Kidney Neoplasms 1Insulin Resistance 1Immunologic Deficiency Syndromes 1Hyperandrogenism 1Hodgkin Disease 1Hematologic Neoplasms 1

Interventions

fludarabine phosphate 3fludarabine 2Whole-Body Irradiation 2Thiotepa 2Melphalan 2Cyclosporins 2Cyclosporine 2Antilymphocyte Serum 2Alemtuzumab 2plerixafor 1Voriconazole 1Tacrolimus 1Photopheresis 1Phlebotomy 1Mycophenolic Acid 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cyclophosphamide 1Clofarabine 1Busulfan 1Blood Specimen Collection 1B-Cell Activating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Immunologic Deficiency Syndromes × Phlebotomy × Clear all
NCT02274662 2025-01-16

Expanded Access Protocol Thymus Transplantation

Sumitomo Pharma Switzerland GmbH

Phase 4 Completed
11 enrolled 10 charts

Thymic aplasia, Immunologic Deficiency Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡